A Low Incidence of Hepatocellular Carcinoma in Patients with Genotype 1B Compensated Cirrhosis Treated with Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir ± Ribavirin in a Tertiary Center: A Matter of Better Selection?

@inproceedings{Chiriac2017ALI,
  title={A Low Incidence of Hepatocellular Carcinoma in Patients with Genotype 1B Compensated Cirrhosis Treated with Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir {\^A}± Ribavirin in a Tertiary Center: A Matter of Better Selection?},
  author={Stefan Andrei Chiriac and Anca Trifan and Carol Stanciu and Cristina Cijevschi Prelipcean and Gabriela Ștefănescu and Cătălina Mihai and Catalin Victor Sfarti and Camelia Cojocariu and Tudor Cuciureanu and Florin Mihai and Ana Maria S{\^i}ngeap},
  year={2017}
}

Topics from this paper.

Similar Papers